Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Igli Arapi"'
Autor:
Jennifer M. Knight, Aniko Szabo, Igli Arapi, Ruizhe Wu, Amanda Emmrich, Edward Hackett, Garrett Sauber, Sharon Yim, Bryon Johnson, Parameswaran Hari, Dina Schneider, Boro Dropulic, Rachel N. Cusatis, Steve W. Cole, Cecilia J. Hillard, Nirav N. Shah
Publikováno v:
Communications Medicine, Vol 2, Iss 1, Pp 1-10 (2022)
Knight et al. assess short-term patient-reported outcomes (PROs) and markers of neurotoxicity in patients with leukaemia or lymphoma treated with LV20.19 CAR T cells. In this small trial cohort, the authors report improvements in mood following CAR T
Externí odkaz:
https://doaj.org/article/56255e90ea724f659420f005396f9009
Autor:
Stacy Reynolds, Igli Arapi, Manish I. Shah, Jonathan R. Studnek, Daniel G Ostermayer, E. Brooke Lerner, Nicole Fumo, Anjishnu Banerjee, Lorin R. Browne
Publikováno v:
Academic Emergency Medicine. 26:510-516
Background Although all emergency departments (EDs) should be ready to treat children, some may have illnesses or injuries that require higher-level pediatric resources that are not available at all hospitals. There are no national guidelines for eme
Autor:
Parameswaran Hari, Igli Arapi, Cecilia J. Hillard, Sharon Yim, Aniko Szabo, Nirav N. Shah, Jennifer M. Knight, Garrett Sauber
Publikováno v:
Blood. 136:42-43
Introduction Chimeric antigen receptor (CAR) T cell immunotherapy represents a novel and increasingly used treatment modality for patients with relapsed and/or refractory B cell malignancies. Acute neurological toxicities of CAR-T cell therapy (e.g.
Autor:
Igli Arapi, Paul S. Ritch, Kathleen K. Christians, Ben George, William A. Hall, Raul Urrutia, Kaitlin Annunzio, Douglas B. Evans, Claire Griffiths, Arun K Singavi, Aniko Szabo, Abdul H. Khan, Matthew Lasowski, Beth Erickson, Kulwinder S. Dua, Mandana Kamgar, James P. Thomas, Susan Tsai
Publikováno v:
Journal of Clinical Oncology. 38:759-759
759 Background: PC is a lethal disease with limited treatment options. We utilized Comprehensive Genomic Profiling (CGP) to identify putative prognostic and/or predictive biomarkers. Methods: We retrospectively reviewed PC patients (pts) at our insti
Autor:
Mandana Kamgar, Douglas B. Evans, Ben George, James P. Thomas, William A. Hall, Matthew Lasowski, Paul S. Ritch, Igli Arapi, Kathleen K. Christians, Abdul H. Khan, Beth Erickson, Susan Tsai, Raul Urrutia, Samantha Stachowiak, Kulwinder S. Dua
Publikováno v:
Web of Science
760 Background: Somatic and germline DDR gene alterations in PC have been postulated to positively predict response to DNA damaging cytotoxic agents. Due to the relatively high prevalence of germline DDR gene alterations, germline testing is recommen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78a29e99cb6b1038f23d428ff62498a3
https://publons.com/publon/52139632/
https://publons.com/publon/52139632/